sequence stringlengths 4 17.9k | seq_id stringlengths 1 6 | pn stringclasses 996
values | title stringclasses 871
values | pbdt int64 20.2M 20.3M | status int64 1 225 ⌀ | family_country listlengths 1 55 | modified_info stringlengths 112 8.31k ⌀ |
|---|---|---|---|---|---|---|---|
acaguacucgcugagggugaa | 726 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
acaguacucgcugagggugaa | 726 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
acaguacucgcugagggugaa | 896 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
acaguacucgcugagggugaa | 896 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
ucaggagucgcgcgcuaggggcc | 1053 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
ucaggagucgcgcgcuaggggcc | 1053 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
ugcgucaaacagcgacaaguu | 346 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
ugcgucaaacagcgacaaguu | 346 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
ugcgucaaacagcgacaaguu | 170 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
ugcgucaaacagcgacaaguu | 170 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
acggccccuagcgcgcgacuccu | 783 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
acggccccuagcgcgcgacuccu | 783 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
acggccccuagcgcgcgacuccu | 953 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
acggccccuagcgcgcgacuccu | 953 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
uauggacuaucaauuauacuu | 212 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
uauggacuaucaauuauacuu | 212 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
uauggacuaucaauuauacuu | 411 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
uauggacuaucaauuauacuu | 411 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
ucaucauugaguacuguaucagc | - | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
ucaucauugaguacuguaucagc | - | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
cugagggugaacaagaaaaga | 642 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
cugagggugaacaagaaaaga | 642 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
cugagggugaacaagaaaaga | 812 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
cugagggugaacaagaaaaga | 812 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
uccagcuguugccaagacagaga | 363 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
uccagcuguugccaagacagaga | 363 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
gcuguugccaagacagagauugc | 367 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
gcuguugccaagacagagauugc | 367 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
gggcgaucuuaacauaauaau | 280 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
gggcgaucuuaacauaauaau | 280 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
gggcgaucuuaacauaauaau | 516 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
gggcgaucuuaacauaauaau | 516 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
cagcuguugccaagacagaga | 180 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
cagcuguugccaagacagaga | 180 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
cagcuguugccaagacagaga | 361 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
cagcuguugccaagacagaga | 361 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
gccuguagcaagcucuggaau | 698 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
gccuguagcaagcucuggaau | 698 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
gccuguagcaagcucuggaau | 868 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
gccuguagcaagcucuggaau | 868 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
agaaguauaauugauaguccaua | 215 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
agaaguauaauugauaguccaua | 215 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
agaaguauaauugauaguccaua | 415 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
agaaguauaauugauaguccaua | 415 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
acaagaaaagaccugauaaagau | 1009 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
acaagaaaagaccugauaaagau | 1009 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
acacuuaaagcaaucucugucuu | 379 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
acacuuaaagcaaucucugucuu | 379 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
acacuuaaagcaaucucugucuu | 191 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
acacuuaaagcaaucucugucuu | 191 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
uguguuuuuguuuuucccacu | 684 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
uguguuuuuguuuuucccacu | 684 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
uguguuuuuguuuuucccacu | 854 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
uguguuuuuguuuuucccacu | 854 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
aguaagcaaaaguagcugcuaau | 193 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
aguaagcaaaaguagcugcuaau | 193 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
aguaagcaaaaguagcugcuaau | 382 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
aguaagcaaaaguagcugcuaau | 382 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
gcugauacaguacucaaugauga | 445 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
gcugauacaguacucaaugauga | 445 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
aagaccugauaaagauuaaccag | 1016 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
aagaccugauaaagauuaaccag | 1016 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
gggugaacaagaaaagaccuu | 714 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
gggugaacaagaaaagaccuu | 714 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
gggugaacaagaaaagaccuu | 884 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
gggugaacaagaaaagaccuu | 884 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
agaguguguguugauagauuaac | 431 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
agaguguguguugauagauuaac | 431 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
ugguuaaucuuuaucaggucuuu | 863 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
ugguuaaucuuuaucaggucuuu | 863 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
ugguuaaucuuuaucaggucuuu | 693 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
ugguuaaucuuuaucaggucuuu | 693 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
aguuuccaucaaagauuaaugaa | 403 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
aguuuccaucaaagauuaaugaa | 403 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
aguuuccaucaaagauuaaugaa | 207 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
aguuuccaucaaagauuaaugaa | 207 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
aauguccagaagauuaucuuaga | 440 | WO2021119226A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
aauguccagaagauuaucuuaga | 440 | WO2021119226A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCÉDÉS D'UTILISATION | 20,210,617 | 224 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
acaactaagctaaattggaaggt | 1516 | EP4161532A2 | IRNA-ZUSAMMENSETZUNGEN AUS TUMORNEKROSEFAKTORREZEPTORASSOZIIERTEM FAKTOR 6 (TRAF6) UND VERFAHREN ZUR VERWENDUNG DAVON | 20,230,412 | 1 | [
"US",
"EP",
"HK",
"WO"
] | null |
acaactaagctaaattggaaggt | 1516 | EP4161532A2 | Tumor necrosis factor receptor associated factor 6 (TRAF6) irna compositions and methods of use thereof | 20,230,412 | 1 | [
"US",
"EP",
"HK",
"WO"
] | null |
acaactaagctaaattggaaggt | 1516 | EP4161532A2 | COMPOSITIONS D'ARNI DU FACTEUR 6 ASSOCIÉ AU RÉCEPTEUR DU FACTEUR DE NÉCROSE TUMORALE (TRAF6) ET LEURS MÉTHODES D'UTILISATION | 20,230,412 | 1 | [
"US",
"EP",
"HK",
"WO"
] | null |
acaactaagctaaattggaaggt | 1430 | EP4161532A2 | IRNA-ZUSAMMENSETZUNGEN AUS TUMORNEKROSEFAKTORREZEPTORASSOZIIERTEM FAKTOR 6 (TRAF6) UND VERFAHREN ZUR VERWENDUNG DAVON | 20,230,412 | 1 | [
"US",
"EP",
"HK",
"WO"
] | null |
acaactaagctaaattggaaggt | 1430 | EP4161532A2 | Tumor necrosis factor receptor associated factor 6 (TRAF6) irna compositions and methods of use thereof | 20,230,412 | 1 | [
"US",
"EP",
"HK",
"WO"
] | null |
acaactaagctaaattggaaggt | 1430 | EP4161532A2 | COMPOSITIONS D'ARNI DU FACTEUR 6 ASSOCIÉ AU RÉCEPTEUR DU FACTEUR DE NÉCROSE TUMORALE (TRAF6) ET LEURS MÉTHODES D'UTILISATION | 20,230,412 | 1 | [
"US",
"EP",
"HK",
"WO"
] | null |
ggaaaacttaagttctcattcac | 391 | EP4161532A2 | IRNA-ZUSAMMENSETZUNGEN AUS TUMORNEKROSEFAKTORREZEPTORASSOZIIERTEM FAKTOR 6 (TRAF6) UND VERFAHREN ZUR VERWENDUNG DAVON | 20,230,412 | 1 | [
"US",
"EP",
"HK",
"WO"
] | null |
ggaaaacttaagttctcattcac | 391 | EP4161532A2 | Tumor necrosis factor receptor associated factor 6 (TRAF6) irna compositions and methods of use thereof | 20,230,412 | 1 | [
"US",
"EP",
"HK",
"WO"
] | null |
ggaaaacttaagttctcattcac | 391 | EP4161532A2 | COMPOSITIONS D'ARNI DU FACTEUR 6 ASSOCIÉ AU RÉCEPTEUR DU FACTEUR DE NÉCROSE TUMORALE (TRAF6) ET LEURS MÉTHODES D'UTILISATION | 20,230,412 | 1 | [
"US",
"EP",
"HK",
"WO"
] | null |
atgttaacgacagaaaaagagag | 1504 | EP4161532A2 | IRNA-ZUSAMMENSETZUNGEN AUS TUMORNEKROSEFAKTORREZEPTORASSOZIIERTEM FAKTOR 6 (TRAF6) UND VERFAHREN ZUR VERWENDUNG DAVON | 20,230,412 | 1 | [
"US",
"EP",
"HK",
"WO"
] | null |
atgttaacgacagaaaaagagag | 1504 | EP4161532A2 | Tumor necrosis factor receptor associated factor 6 (TRAF6) irna compositions and methods of use thereof | 20,230,412 | 1 | [
"US",
"EP",
"HK",
"WO"
] | null |
atgttaacgacagaaaaagagag | 1504 | EP4161532A2 | COMPOSITIONS D'ARNI DU FACTEUR 6 ASSOCIÉ AU RÉCEPTEUR DU FACTEUR DE NÉCROSE TUMORALE (TRAF6) ET LEURS MÉTHODES D'UTILISATION | 20,230,412 | 1 | [
"US",
"EP",
"HK",
"WO"
] | null |
atgttaacgacagaaaaagagag | 1418 | EP4161532A2 | IRNA-ZUSAMMENSETZUNGEN AUS TUMORNEKROSEFAKTORREZEPTORASSOZIIERTEM FAKTOR 6 (TRAF6) UND VERFAHREN ZUR VERWENDUNG DAVON | 20,230,412 | 1 | [
"US",
"EP",
"HK",
"WO"
] | null |
atgttaacgacagaaaaagagag | 1418 | EP4161532A2 | Tumor necrosis factor receptor associated factor 6 (TRAF6) irna compositions and methods of use thereof | 20,230,412 | 1 | [
"US",
"EP",
"HK",
"WO"
] | null |
atgttaacgacagaaaaagagag | 1418 | EP4161532A2 | COMPOSITIONS D'ARNI DU FACTEUR 6 ASSOCIÉ AU RÉCEPTEUR DU FACTEUR DE NÉCROSE TUMORALE (TRAF6) ET LEURS MÉTHODES D'UTILISATION | 20,230,412 | 1 | [
"US",
"EP",
"HK",
"WO"
] | null |
acaacagacatgtttacactaaa | 303 | EP4161532A2 | IRNA-ZUSAMMENSETZUNGEN AUS TUMORNEKROSEFAKTORREZEPTORASSOZIIERTEM FAKTOR 6 (TRAF6) UND VERFAHREN ZUR VERWENDUNG DAVON | 20,230,412 | 1 | [
"US",
"EP",
"HK",
"WO"
] | null |
acaacagacatgtttacactaaa | 303 | EP4161532A2 | Tumor necrosis factor receptor associated factor 6 (TRAF6) irna compositions and methods of use thereof | 20,230,412 | 1 | [
"US",
"EP",
"HK",
"WO"
] | null |
acaacagacatgtttacactaaa | 303 | EP4161532A2 | COMPOSITIONS D'ARNI DU FACTEUR 6 ASSOCIÉ AU RÉCEPTEUR DU FACTEUR DE NÉCROSE TUMORALE (TRAF6) ET LEURS MÉTHODES D'UTILISATION | 20,230,412 | 1 | [
"US",
"EP",
"HK",
"WO"
] | null |
acaacagacatgtttacactaaa | 123 | EP4161532A2 | IRNA-ZUSAMMENSETZUNGEN AUS TUMORNEKROSEFAKTORREZEPTORASSOZIIERTEM FAKTOR 6 (TRAF6) UND VERFAHREN ZUR VERWENDUNG DAVON | 20,230,412 | 1 | [
"US",
"EP",
"HK",
"WO"
] | null |
acaacagacatgtttacactaaa | 123 | EP4161532A2 | Tumor necrosis factor receptor associated factor 6 (TRAF6) irna compositions and methods of use thereof | 20,230,412 | 1 | [
"US",
"EP",
"HK",
"WO"
] | null |
acaacagacatgtttacactaaa | 123 | EP4161532A2 | COMPOSITIONS D'ARNI DU FACTEUR 6 ASSOCIÉ AU RÉCEPTEUR DU FACTEUR DE NÉCROSE TUMORALE (TRAF6) ET LEURS MÉTHODES D'UTILISATION | 20,230,412 | 1 | [
"US",
"EP",
"HK",
"WO"
] | null |
attcgtggttttgccttataagt | 1733 | EP4161532A2 | IRNA-ZUSAMMENSETZUNGEN AUS TUMORNEKROSEFAKTORREZEPTORASSOZIIERTEM FAKTOR 6 (TRAF6) UND VERFAHREN ZUR VERWENDUNG DAVON | 20,230,412 | 1 | [
"US",
"EP",
"HK",
"WO"
] | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.